We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

National Registry of Genetically Triggered Thoracic Aortic Aneurysms and Cardiovascular Conditions (GenTAC)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT01322165
Recruitment Status : Completed
First Posted : March 24, 2011
Last Update Posted : December 20, 2016
Sponsor:
Collaborator:
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Information provided by (Responsible Party):
National Heart, Lung, and Blood Institute (NHLBI)

Brief Summary:
The National Registry of Genetically Triggered Thoracic Aortic Aneurysms and Cardiovascular Conditions (GenTAC) was initiated in 2006 by the National Heart, Lung, and Blood Institute (NHLBI) and the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS). GenTAC established a registry of 3706 patients with genetic conditions that may be related to thoracic aortic aneurysms and collected medical data and biologic samples. The study ended in September 2016. Data and samples are available from NHLBI and requests should be made to BioLINCC. See the NHLBI website for more information: https://www.nhlbi.nih.gov/research/resources/gentac/.

Condition or disease
Marfan Syndrome Turner Syndrome Ehlers-Danlos Syndrome Loeys-Dietz Syndrome FBN1, TGFBR1, TGFBR2, ACTA2 or MYH11 Genetic Mutation Bicuspid Aortic Valve Without Known Family History Bicuspid Aortic Valve With Family History Bicuspid Aortic Valve With Coarctation Familial Thoracic Aortic Aneurysm and Dissections Shprintzen-Goldberg Syndrome Other Aneur/Diss of Thoracic Aorta Not Due to Trauma, <50yo Other Congenital Heart Disease

Layout table for study information
Study Type : Observational
Actual Enrollment : 3706 participants
Observational Model: Cohort
Time Perspective: Prospective
Official Title: National Registry of Genetically Triggered Thoracic Aortic Aneurysms and Cardiovascular Conditions
Study Start Date : November 2007
Actual Primary Completion Date : September 2015
Actual Study Completion Date : September 2016





Primary Outcome Measures :
  1. Thoracic aortic aneurysms and dissections and their associated surgical interventions [ Time Frame: bi-annual ]

Biospecimen Retention:   Samples With DNA
If a blood specimen is obtained, it is separated and stored as plasma, viable cells, and extracted DNA. If a saliva specimen is obtained, it is stored for DNA.


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   Child, Adult, Older Adult
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
The cohort consists of patients with conditions related to genetically-induced thoracic aortic aneurysms.
Criteria

Eligible subjects must have one of the conditions listed below and be enrolled in-person at one of the participating clinical centers.Contact the study coordinator at the location nearest you for more information about participation.

  • Marfan syndrome
  • Turner syndrome
  • Ehlers-Danlos syndrome
  • Loeys-Dietz syndrome
  • FBN1, TGFBR1, TGFBR2, ACTA2 or MYH11 genetic mutation
  • Bicuspid aortic valve without known family history
  • Bicuspid aortic valve with family history
  • Bicuspid aortic valve with coarctation
  • Familial Thoracic Aortic Aneurysm and DissectionsYes
  • Shprintzen-Goldberg syndrome
  • Other aneurysms and dissections of the thoracic aorta not due to trauma, <50yo
  • Other congenital heart disease (e.g., Tetralogy of Fallot, coarctation)

Exclusion Criteria:

  • Inability of the patient, parent or guardian to give consent.
  • Unwillingness to provide a blood or buccal specimen.

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01322165


Locations
Layout table for location information
United States, Hawaii
Queens Medical Center
Honolulu, Hawaii, United States, 96813
United States, Maryland
Johns Hopkins University
Baltimore, Maryland, United States, 21287
United States, New York
The New York Presbyterian Hospital-Weill Cornell Medical Center
New York, New York, United States, 10021
United States, Oregon
Oregon Health & Science University
Portland, Oregon, United States, 97239
United States, Pennsylvania
University of Pennsylvania School of Medicine
Philadelphia, Pennsylvania, United States, 19104-4283
United States, Texas
Baylor College of Medicine
Houston, Texas, United States, 77030
University of Texas Medical School at Houston
Houston, Texas, United States, 77030
Sponsors and Collaborators
National Heart, Lung, and Blood Institute (NHLBI)
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Investigators
Layout table for investigator information
Study Director: Barbara Kroner, PhD, MPH RTI International
Principal Investigator: Richard Devereux, MD The New York Presbyterian Hospital-Weill Cornell Medical Center
Principal Investigator: William Ravekes, M.D. Johns Hopkins University
Principal Investigator: Reed E. Pyeritz, M.D., Ph.D. University of Pennsylvania
Principal Investigator: Dianna M. Milewicz, M.D. Ph.D. University of Texas Medical School at Houston
Principal Investigator: Scott A. LeMaire, M.D. Baylor College of Medicine
Principal Investigator: Cheryl L. Maslen, Ph.D. Oregon Health and Science University
Principal Investigator: Ralph Shohet, MD University of Hawaii
Principal Investigator: Jennifer Habashi, MD Johns Hopkins University
Principal Investigator: Federico M. Asch, MD,FACC,FASE Medstar
Study Chair: Kim Eagle, M.D. University of Michigan
Additional Information:
Publications of Results:

Other Publications:

Layout table for additonal information
Responsible Party: National Heart, Lung, and Blood Institute (NHLBI)
ClinicalTrials.gov Identifier: NCT01322165    
Other Study ID Numbers: 1438
268201000048C-5-0-1 ( U.S. NIH Grant/Contract )
N01HV68199-7-0-1 ( U.S. NIH Grant/Contract )
First Posted: March 24, 2011    Key Record Dates
Last Update Posted: December 20, 2016
Last Verified: December 2016
Keywords provided by National Heart, Lung, and Blood Institute (NHLBI):
Marfan syndrome
Turner syndrome
Bicuspid aortic valve
Ehlers-Danlos Syndrome
Loeys-Dietz syndrome
Aneurysm
Genetic
aortic
thoracic
mutation
dissection
Additional relevant MeSH terms:
Layout table for MeSH terms
Marfan Syndrome
Arachnodactyly
Loeys-Dietz Syndrome
Turner Syndrome
Gonadal Dysgenesis
Heart Diseases
Aneurysm, Dissecting
Aneurysm
Aortic Aneurysm
Heart Defects, Congenital
Ehlers-Danlos Syndrome
Bicuspid Aortic Valve Disease
Aortic Aneurysm, Thoracic
Heart Valve Diseases
Syndrome
Disease
Pathologic Processes
Cardiovascular Diseases
Vascular Diseases
Aortic Diseases
Cardiovascular Abnormalities
Congenital Abnormalities
Disorders of Sex Development
Urogenital Abnormalities
Sex Chromosome Disorders of Sex Development
Sex Chromosome Disorders
Chromosome Disorders
Genetic Diseases, Inborn
Gonadal Disorders
Endocrine System Diseases